Influenza

Data show a 23.5% increase in influenza vaccination rates.

ClearUp Sinus Pain Relief treatment was previously approved for allergy-related sinus and nasal congestion and allergy-related sinus pain.

The approval is based on absolute efficacy data from 3 influenza seasons.

Compared with US census data, White individuals and women are overrepresented in clinical trials.

Women were more likely than men to get the influenza vaccine, but less likely to receive the high-dose version.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

An expert weighs in on the strengths, makeup, and timeframe of current and upcoming vaccine options.

A meta-analysis review suggests intradermal flu vaccines at lower doses could provide as much immunogenicity as standard intramuscular doses.

Participants who received the vaccine intranasally or through the tonsillar swab had significantly higher H5-specific neutralizing antibody levels than the group that received the vaccine orally.

There was a positive rate of 9.88 positive results per 100 tests during a 4 month period in 2020, significantly lower than the positivity rate of 29.90 positive results per 100 tests observed for the same date range during the previous 5 virus years.

Older adults and patients with chronic conditions are more vulnerable to severe influenza disease.

New data suggests a clear benefit to adjuvanted flu vaccines in elderly populations.

After 7 days post-vaccination, some common adverse events of interest included wheezing, nasal congestion, and cough.

The clinical presentation of influenza myocarditis includes, fever, myalgia, palpitations, shortness of breath, and chest pains.

An individualized model that provides vaccine-hesitant patients resources without compromising autonomy could aid efforts to limit the pandemic with new vaccines.

The randomized, blinded trial evaluated the safety and reactogenicity of aIIV3 and HD-IIV3 in adults 65 and older.

A seven-question quiz comparing the respiratory viruses. Can you pass it?

There are currently 14 states with laws either encouraging or requiring influenza vaccination for hospital workers.

Elevated cardiac troponins during hospitalization for influenza is associated with heightened risk of mortality after hospital discharge.

Influenza vaccination not only protects against the flu, but could lessen the severity of COVID-19.

Point of care test-and-treat strategy for influenza improves efficiency of hospital triage and the clinical outcomes for patients with acute respiratory illness.

Oseltamivir and zanamivir are compared in acute treatment of patients with severe influenza type-A H1N1 in China.

A discussion with a survey researcher on the 35% of US adults who state they won't get the vaccine this season.

Using French data, there were 3 times as many deaths from COVID-19 than the Flu in France, despite a shorter study time.

There were similar rates of primary outcome events in the high-dose and standard-dose vaccination groups.

Throughout the COVID-19 pandemic, the US has shown its lessening interest in mitigating the more manageable virus, influenza. Is there a chance to change course?

Our annual series is touching on the stories in medicine that occurred during this unforgettable time.

The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.

ContagionLive releases their latest e-book on this year's flu season, which includes expert-led opinions and interviews.